Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.01 - $0.02 $77 - $155
-7,750 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$0.01 - $0.02 $77 - $155
7,750 New
7,750 $6,000

Others Institutions Holding ATHE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About ALTERITY THERAPEUTICS LTD


  • Ticker ATHE
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,114,600
  • Market Cap $88.7M
  • Description
  • Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...
More about ATHE
Track This Portfolio

Track Tcwp LLC Portfolio

Follow Tcwp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcwp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcwp LLC with notifications on news.